Proprietary Therapeutics Pipeline
Large market applications (Immunology, Oncology)
Pre-clinical (inferred)Active
Key Facts
Indication
Large market applications (Immunology, Oncology)
Phase
Pre-clinical (inferred)
Status
Active
Company
About KSL Biomedical
KSL Biomedical is a diversified, privately-held biotech services and development company. Its core business model integrates proprietary diagnostic development, a pipeline of therapeutic assets, and a comprehensive CRO offering that includes regulatory strategy, clinical studies, and sample biobanking. Through strategic acquisitions, KSL has built an integrated network of clinical laboratories in the US and Canada, positioning it as a one-stop partner for diagnostics and therapeutic companies navigating complex development and regulatory pathways, particularly in the US and China.
View full company profile